![]() |
市場調查報告書
商品編碼
1726420
精準醫療時代的醫學事務-駕馭複雜性,推動進步:專家問答Expert Q&A: Medical Affairs in the Precision Medicine Era - Navigating Complexity, Enabling Progress |
醫學事務團隊在精準醫療領域,在彌合尖端科學與臨床實踐之間的差距方面發揮著關鍵作用。他們不僅是數據共享者,還與研究人員和醫療保健專業人員 (HCP) 密切合作,整合基因組學、生物標記和臨床洞察,將複雜的分子數據轉化為服務於不同患者群體的個人化治療策略。
FirstWord 訪問了艾伯維腫瘤全球和美國醫學事務副總裁 Svetlana Kobina,探討了醫學事務在精準醫療中不斷演變的角色、其中蘊含的機會和課題,以及艾伯維如何努力改善患者治療效果。
檔案報告是基於獨立而簡潔的分析,這些分析源自於專有的產業研究以及對產業思想領袖的深入訪談。我們的報告深入分析了製藥公司主管需要了解的關鍵發展和市場趨勢,以應對未來的機會和課題。每份報告的重點都基於對二手文獻的回顧和已發現的知識差距。基於這些初步研究,我們制定了基於證據、專家意見的討論指南,以確保我們的研究能夠解答最重要的問題。此外,我們採用嚴格的篩選標準,以確保受訪者有足夠的經驗、知識和資格就該主題發表意見。
FirstWord Reports 是值得信賴的行業領導者,專注於製藥業,為生物製藥專業人士和決策者提供深入、可操作的洞察。我們深厚的行業知識使我們能夠為您提供相關且有價值的洞察,幫助您掌握新興趨勢並有效應對複雜課題。憑藉廣泛的研究以及來自領先專家和關鍵意見領袖的獨立、公正的見解,我們的報告能夠為您提供所需的準確性和可靠性。獨家訪談和數據,以及持續的市場監測,讓您可以全面洞察市場動態。我們的報告涵蓋 40 多個活躍疾病領域,包含 KOL 洞察和定量醫生調查等醫生情報,以及行業專家對醫療事務、數位健康、銷售與行銷、市場准入及其他領域問題的看法,助您做出更明智的數據驅動決策,在快速變化的行業中保持競爭力。
Medical affairs teams are a crucial link between advanced science and clinical practice in precision medicine. Not just data sharers, they integrate genomic, biomarker and clinical insights in close collaboration with researchers and healthcare professionals (HCPs) to translate complex molecular data into personalized treatment strategies to benefit diverse patient populations.
FirstWord spoke with Svetlana Kobina, vice president of oncology global and US medical affairs at AbbVie, about how the role of medical affairs is evolving in precision medicine, the associated opportunities and challenges, and how AbbVie is addressing them to enhance patient outcomes.
Dossier reports are developed from independent and concise analysis derived from original industry surveys and in-depth interviews with industry thought leaders. Reports analyse in detail significant developments and market trends that pharma executives need to understand if they are to manage the opportunities and challenges that lie ahead. The focus of each report is defined by a review of the secondary literature and any knowledge gaps identified. Based on this initial research, an evidence-based and expert-informed discussion guide is developed to ensure the research answers the most critical questions. Additionally, robust screening criteria are established to ensure that those interviewed are qualified in terms of their experience, knowledge and stature to speak on the topic.
FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.